![]()
Phenotype Annotations Click to see Annotation Detail View
Mammalian PhenotypeTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | albuminuria | induced | IAGP | XCO:0000795 | 12802368 | | RGD | | albuminuria | induced | IAGP | XCO:0000022 | 12802369 | | RGD | | cardiac hypertrophy | induced | IAGP | XCO:0000022 | 727992 | | RGD | | decreased body weight | induces | IAGP | XCO:0000245,XCO:0000241 | 149735534 | compared to wild type and SS-Trpc6em1Mcwi vehicle-treated control | RGD | | decreased coronary flow rate | induced | IAGP | XCO:0000464,XCO:0000010 | 1342469 | | RGD | | decreased heart rate | induced | IAGP | XCO:0000464,XCO:0000010 | 1342469 | | RGD | | decreased left ventricle developed pressure | induced | IAGP | XCO:0000464,XCO:0000010 | 1342469 | | RGD | | decreased mean systemic arterial blood pressure | induced | IAGP | XCO:0000645 | 1626639 | compared to BN/NHsdMcwi, lower infusion of anesthetic propofol. | RGD | | decreased tubuloglomerular feedback response | | IAGP | | 12792230 | compared to SS-Chr 2BN/Mcwi more ... | RGD | | glomerulosclerosis | induces | IAGP | XCO:0000245,XCO:0000241 | 149735534 | compared to wild type vehicle-treated control | RGD | | heart left ventricle hypertrophy | induced | IAGP | XCO:0000022 | 727992 | | RGD | | increased body weight | induces | IAGP | XCO:0000245,XCO:0000241 | 149735534 | compared to wild type and SS-Trpc6em1Mcwi vehicle-treated control | RGD | | increased circulating cholesterol level | induced | IAGP | XCO:0000022 | 727992 | compared to BN/NHsdMcwi | RGD | | increased circulating creatinine level | induced | IAGP | XCO:0000022 | 727992 | compared to BN/NHsdMcwi | RGD | | increased circulating triglyceride level | induced | IAGP | XCO:0000022 | 727992 | compared to BN/NHsdMcwi | RGD | | increased creatinine clearance | induces | IAGP | XCO:0000245,XCO:0000241 | 149735534 | compared to wild type and SS-Trpc6em1Mcwi | RGD | | increased heart rate | induced | IAGP | XCO:0000022 | 727992 | compared to BN/NHsdMcwi | RGD | | increased kidney weight | induced | IAGP | XCO:0000022 | 727992 | compared to BN/NHsdMcwi | RGD | | increased mammary adenocarcinoma incidence | induced | IAGP | XCO:0000090 | 2301186 | compared to BN/NHsdMcwi | RGD | | increased mean systemic arterial blood pressure | induced | IAGP | XCO:0000022 | 2300225 | compared to BN/NHsdMcwi | RGD | | increased urine flow rate | induces | IAGP | XCO:0000245,XCO:0000241 | 149735534 | compared to wild type and SS-Trpc6em1Mcwi vehicle-treated control | RGD | | increased urine microalbumin level | induces | IAGP | XCO:0000245,XCO:0000241 | 149735534 | compared to vehicle-treated control | RGD | | increased urine protein level | induced | IAGP | XCO:0000022 | 727992 | compared to BN/NHsdMcwi | RGD | | increased vasoconstriction | induced | IAGP | XCO:0000022,XCO:0000612 | 12792230 | compared to SS-Shc1em5Mcwi | RGD | | podocyte foot process effacement | induces | IAGP | XCO:0000245,XCO:0000241 | 149735534 | compared to control and STZ treated SS-Trpc6em1Mcwi | RGD | | renal cast | | IAGP | | 38500204 | compared to SS-Kcnj16em1Mcwi | RGD | | salt-sensitive hypertension | induced | IAGP | XCO:0000022 | 727992; 12802369 | | RGD | | salt-sensitive hypertension | induced | IAGP | XCO:0000795 | 12802368 | | RGD | | salt-sensitive hypertension | treatment | IAGP | XCO:0000022,XCO:0000032 | 38500204 | compared to SS-Kcnj16em1Mcwi | RGD | | salt-sensitive hypertension | | IAGP | | 12798539 | | RGD | | |